Quantitative evaluation of safety in drug development :
General Material Designation
[Book]
Other Title Information
design, analysis and reporting /
First Statement of Responsibility
edited by Qi Jiang, Amgen Inc, Thousand Oaks, California, USA, H. Amy Xia, Amgen Inc, Thousand Oaks, California, USA.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
xv, 349 pages :
Other Physical Details
illustrations (some color) ;
Dimensions
24 cm.
SERIES
Series Title
Chapman & Hall/CRC biostatistics series
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
Incorporating quantitative safety evaluation into risk management / Jüergen Küebler -- Bayesian metaexperimental design for evaluating cardiovascular risk / Joseph G. Ibrahim, Ming-Hui Chen, H. Amy Xia, Thomas Liu and Violeta Hennessey -- Non-inferiority study design and analysis for safety endpoints / /Steven Snapinn and Qi Jiang -- Program safety analysis plan : an implementation guide / Brenda Crowe, H. Amy Xia, Mary Nilsson, Seta Shahin, Wei Wang, and Qi Jiang -- Why a DMC safety report differs from a safety section written at the end of the trial / Mark Schactman and Janet Wittes -- Safety surveillance and signal detection process / Atsuko Shibata and José M. Vega -- Bayesian adaptive trials for drug safety / Jason T. Connor -- Observational safety study design, analysis, and reporting / Hong Qiu, Jesse A. Berlin, and Paul E. Stang -- Emerging role of observational health-care data in pharmacovigilance / Patrick Ryan, David Madigan, and Martijn Schuemie -- Roadmap for causal inference in safety analysis / Jordan C. Brooks, Alan S. Go, Daniel E. Singer, and Mark J. van der Laan -- Safety graphics / Susan P. Duke, Qi Jiang, Liping Huang, Mary Banach, and Max Cherny -- Bayesian network meta-analysis for safety evaluation / Bradley P. Carlin and Hwanhee Hong -- Regulatory issues in meta-analysis of safety data / Aloka G. Chakravarty and Mark Levenson -- Bayesian applications for drug safety evaluation / H. Amy Xia and Karen L. Price -- Benefit-risk assessment approaches / Chunlei Ke, Qi Jiang, and Steven Snapinn -- Detecting safety signals in subgroups / Christy Chuang-Stein, Yoichi Ii, Norisuke Kawai, Osamu Komiyama and Kazuhiko Kuribayashi -- Overview of safety evaluation and quantitative approaches from preclinical and early phases of drug development / John Sullivan and Hisham Hamadeh.